24/7 Pet Web Search

Search results

1. Results From The WOW.Com Content Network

2. How the Wheels Came Off Meridian Bioscience's Bus - AOL

   www.aol.com/news/2012-01-25-how-the-wheels-came...

   Meridian Bioscience (NAS: VIVO) reported earnings on Jan. 25. ... The stock has a five-star rating (out of five) at Motley Fool CAPS, with 463 members out of 474 rating the stock outperform, and ...

3. Meridian Bioscience (VIVO) Beats Q2 Earnings Estimates - AOL

   www.aol.com/news/meridian-bioscience-vivo-beats...

   Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 16.67% and -2.26%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4. What to Expect From Meridian Bioscience - AOL

   www.aol.com/news/2012-07-25-what-to-expect-from...

   Last quarter, Meridian Bioscience tallied revenue of $47.4 million. GAAP reported sales were 16% higher than the prior-year quarter's $41.1 million. Source: S&P Capital IQ.

5. The Meridian Bioscience (NASDAQ:VIVO) Share Price Has ... - AOL

   www.aol.com/news/meridian-bioscience-nasdaq-vivo...

   While Meridian Bioscience, Inc. (NASDAQ:VIVO) shareholders are probably generally happy, the stock hasn't had...

6. 5-Star Stocks Poised to Pop: Meridian Bioscience - AOL

   www.aol.com/2012/09/16/5-star-stocks-poised-to...

   Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, diagnostic test maker Meridian Bioscience (NAS: VIVO) has ...

7. Are Institutions Heavily Invested In Meridian Bioscience, Inc ...

   www.aol.com/news/institutions-heavily-invested...

   A look at the shareholders of Meridian Bioscience, Inc. (NASDAQ:VIVO) can tell us which group is most powerful... Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call ...

8. Why Meridian Bioscience Is Poised to Outperform - AOL

   www.aol.com/news/2013-01-23-why-meridian...

   Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, diagnostic test maker Meridian Bioscience has earned a ...

9. Fool Checkup: Meridian Bioscience Earnings

   www.aol.com/news/2013-04-26-fool-checkup...

   The 10-second takeaway For the quarter ended March 31 (Q2), Meridian Bioscience missed estimates on revenues and met expectations on earnings. Meridian Bioscience (NAS: VIVO) reported earnings on ...